The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China, Oct. 25, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as the "Company") today announced the successful...
Hence then, the article about cardiovalve completes target study enrollment for ce registration study for tricuspid valve replacement was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement )
Also on site :
- 1969 Neil Diamond Classic, Written in Less Than One Hour, Remains Pop Culture’s Favorite ‘Reason to Smile’
- Breakout Comedian Recalls ‘SNL’s Lorne Michaels Forcing Him to Fly Back to New York to be Rejected from the Series: ‘Like, This is Wild’
- I Toured JetBlue’s New BlueHouse Lounge at Boston Logan—Here’s a Look Inside the Cozy, Locally Inspired Space